The efforts over the past year by the team at Keros have positioned us to continue to advance our promising pipeline of novel therapeutics,” said Jasbir S. Seehra, Ph.D., Chair and Chief Executive ...
Corundum Systems Biology, an investment firm supporting early-stage companies developing biomedical solutions, hired operating partner Henry Haiser, PhD from Takeda and Rotem Gura-Sadovsky, PhD as ...
Reports Q4 revenue $3.04M vs. $143,000 last year. “The efforts over the past year by the team at Keros have positioned us to continue to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback